mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.9 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |